SCHEMBL18115648

SCHEMBL18115648

CC(C)(C)N1CC(O)(c2ccccc2)C1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.58
OPRM1 P35372 12/20 0.52
GRIN2D O15399 1/20 0.52
GRIN3B O60391 1/20 0.52
CHRM2 P08172 1/20 0.52
CHRM1 P11229 1/20 0.52
GRIN1 Q05586 1/20 0.52
KCNH2 Q12809 1/20 0.52
GRIN2A Q12879 1/20 0.52
GRIN2B Q13224 1/20 0.52
GRIN2C Q14957 1/20 0.52
GRIN3A Q8TCU5 1/20 0.52
OPRL1 P41146 14/20 0.47
OPRK1 P41145 11/20 0.47
OPRD1 P41143 9/20 0.45
POLB P06746 1/20 0.42
HSD11B1 P28845 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24422207 0.85 OPRM1 (0.59) ALDH1A1OPRM1GRIN2DGRIN3BCHRM2
SCHEMBL12363963 0.83 OPRM1 (0.51) ALDH1A1OPRM1GRIN2DGRIN3BCHRM2
SCHEMBL2629517 0.82 OPRM1 (0.70) OPRM1GRIN2DGRIN3BCHRM2CHRM1
Hydrochloric Acid SCHEMBL10752401 0.81 OPRM1 (0.50) ALDH1A1OPRM1GRIN2DGRIN3BCHRM2
SCHEMBL15543215 0.81 OPRM1 (0.43) ALDH1A1OPRM1CHRM1KCNH2OPRL1
SCHEMBL23748779 0.79 CCR1 (0.42) ALDH1A1OPRM1GRIN2DGRIN3BCHRM2
SCHEMBL23748773 0.78 OPRM1 (0.37) ALDH1A1OPRM1GRIN2DGRIN3BGRIN1
SCHEMBL24421814 0.78 ALDH1A1 (0.37) ALDH1A1OPRM1GRIN2DGRIN3BCHRM2
SCHEMBL569815 0.78 ALDH1A1 (0.37) ALDH1A1OPRM1GRIN2DGRIN3BCHRM2
SCHEMBL9966015 0.77 OPRM1 (0.48) ALDH1A1OPRM1GRIN2BOPRL1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220144838-A1 Compounds as Inhibitors of Macrophage Migration Inhibitory Factor Nanjing Immunophage Biotech Co., Ltd. (CN) 2022-05-12 US disclosed
EP-3277677-A1 1-CYANO-PYRROLIDINE COMPOUNDS AS USP30 INHIBITORS Mission Therapeutics Limited (GB) 2018-02-07 EP disclosed
WO-2016156816-A1 1-CYANO-PYRROLIDINE COMPOUNDS AS USP30 INHIBITORS MISSION THERAPEUTICS LIMITED (GB) 2016-10-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220144838-A1 Compounds as Inhibitors of Macrophage Migration Inhibitory Factor MIF, MMP12, SLC11A2 ALDH1A1 2121/4885OPRM1 2541/4885GRIN2D 3746/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.